Q1 Earnings Estimate for SLDB Issued By Leerink Partnrs

Solid Biosciences Inc. (NASDAQ:SLDB – Free Report) – Investment analysts at Leerink Partnrs issued their Q1 2025 EPS estimates for shares of Solid Biosciences in a research note issued on Monday, April 21st. Leerink Partnrs analyst J. Schwartz expects that the company will earn ($0.41) per share for the quarter. The consensus estimate for Solid […]

Leave a Reply

Your email address will not be published.

Previous post Roth Capital Analysts Decrease Earnings Estimates for IMAX
Next post Q1 EPS Estimates for PDS Biotechnology Increased by B. Riley